CTSO vs IDXX · rev $18.5M vs P/E 40, rev $2.36B
Cytosorbents Crp (CTSO) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Cytosorbents Crp (CTSO) is a medical devices company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported CTSO revenue for 2026-06-30 was $18.5M. Net income was -$9.5M. CTSO currently screens at market cap $28.8M.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
CTSO currently screens at market cap $28.8M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the CTSO and IDXX stock pages for the full models.
Not investment advice.